Sunshine Biopharma priced a $6.0 million public offering at 8:00 AM ET. The market values the entire company at about $3M.
$SBFM is -28.57% pre-market, and the reason is arithmetic, not mood. The raise is roughly twice the company's market value. The feed doesn't carry the per-share price, but you can see the shape without it. The company walks out with more fresh cash than the market thinks the whole business is worth, and every existing share owns a thinner piece of it.
Cash went up. Ownership per share went down. The headline only mentions the first.
Here is the stock's own record. In 24 prior sessions, SBFM gapped down at least 5% at the open. It closed below that open in 58% of them and above it in 42%, with a median open-to-close move of -1.48%. That is this ticker's history, not a forecast for this morning.